[1]
N. Khalili, MD, A. Sabahi, MD, M. Vahedian, PhD, and M. Alimardanzadeh, MD, “A double blind randomized clinical trial of buprenorphine augmentation for treatment of psychotic symptoms in opioid addicted bipolar patients”, J of Opioid Management, vol. 15, no. 5, pp. 362–366, Sep. 2019.